Showing results (1451-1460 of 1,558) with videos related to

Sort By:
Pageof 156
JCO Oncology Practice|November 18, 2025
Accuracy of Computed Tomography Staging of Mismatch Repair-Deficient Colon CancerSamantha M Linhares, Thejal Srikumar, Clifford Shin, et al.
JCO Oncology Practice|November 18, 2025
Systemic Therapy for Muscle-Invasive Urothelial Carcinoma of the Bladder (Muscle-Invasive Bladder Cancer): Insights From Real-World DataSarmad Sadeghi, Primo N Lara, Andrea Necchi, et al.
JCO Oncology Practice|December 4, 2025
Outpatient Administration of Bispecific Antibody Therapy for Hematologic Malignancies: A Practical GuideKian J Rahbari, Raul Del Toro Mijares, Kathryn Kennedy, et al.
JCO Oncology Practice|December 17, 2024
Efficacy of Subsequent Treatments After Disease Progression on CDK4/6 Inhibitors in Patients With Hormone Receptor-Positive Advanced Breast CancerLis Victoria Ravani, Pedro Calomeni, Maysa Vilbert, et al.
JCO Oncology Practice|December 19, 2024
Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is NowNeal Shore, Sarah M Nielsen, Edward D Esplin, et al.
JCO Oncology Practice|January 10, 2025
Development and Validation of a Simplified Financial Toxicity Screening Tool for Use in Clinical PracticeBridgette Thom, Amy L Tin, Fumiko Chino, et al.
JCO Oncology Practice|December 20, 2024
Real-World Treatment Patterns After Discontinuation of Venetoclax or BTKis in the Frontline Setting Among Older Adults With Chronic Lymphocytic LeukemiaScott F Huntington, Joanna M Rhodes, Beenish S Manzoor, et al.
JCO Oncology Practice|January 6, 2025
Randomized Trial of Enhanced Versus Standard Navigation to Promote Timely Initiation of Adjuvant Radiotherapy for Head and Neck CancerEvan M Graboyes, Reid DeMass, Katherine R Sterba, et al.
JCO Oncology Practice|January 10, 2025
Addressing Financial Toxicity From a Global Perspective: How to Advance Shared-Learning to Facilitate Change?Raymond Javan Chan, Yu Ke, Pricivel Carerra, et al.
JCO Oncology Practice|February 7, 2025
Real-World Evidence of Combination Therapy Use in Metastatic Hormone-Sensitive Prostate Cancer in the United States From 2017 to 2023Amit D Raval, Orsolya Lunacsek, Matthew J Korn, et al.
Pageof 156